Riskpilot← Back to searchSign inGet full accessImplant Solutions West AB
ABActiveOrg 5590294186Väverigatan 14Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20151-4 employees
Revenue 2024
SEK 17,9M
+14% vs 2023
EBITDA margin
5.3%
+17% vs 2023
Equity ratio
17.3%
Financial strength
Net profit 2024
SEK 780K
+31% vs 2023
| Revenue | SEK 17,9M | +14% |
| EBITDA | SEK 942K | +17% |
| Net profit | SEK 780K | +31% |
| Total assets | SEK 7,9M | +21% |
| Equity | SEK 1,4M | -1% |
| Employees | — | — |
Legal name
Implant Solutions West AB
Org number
5590294186
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
7 oktober 2015
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva försäljning av medicinsk utrustning och därmed förenlig verksamhet.
Address
Väverigatan 14
Email
johan@implantsolutions.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7 984 | 9 988 | 13 771 | 15 639 | 17 851 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 556 | 614 | 1 245 | 807 | 942 |
| Depreciation & amort. | −21 | −30 | −31 | −9 | −0 |
| EBIT | 535 | 584 | 1 214 | 798 | 942 |
| Net financials | — | −4 | −98 | −39 | −62 |
| Profit before tax | 535 | 581 | 1 116 | 758 | 991 |
| Tax | −117 | −123 | −236 | −161 | −211 |
| Net profit | 418 | 458 | 880 | 597 | 780 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 402 | 4 726 | 5 611 | 6 533 | 7 886 |
| Equity | 750 | 1 207 | 1 587 | 1 384 | 1 364 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3 543 | 3 409 | 3 914 | 5 039 | 6 522 |
| Total debt | 3 543 | 3 409 | 3 914 | 5 039 | 6 522 |
EBITDA margin
5.3%
This company
15.8%
Market median
-66% vs market
20202024
Equity ratio
17.3%
This company
38.2%
Market median
-55% vs market
20202024
Return on equity
57.2%
This company
18.4%
Market median
+211% vs market
20202024
Net profit margin
4.4%
This company
8.1%
Market median
-46% vs market
20202024
Asset turnover
2.26×
This company
1.12×
Market median
+102% vs market
20202024
Debt / equity
4.78×
This company
0.62×
Market median
-671% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AS | Audit | 2021 |
| Former (1) | ||
NL | Audit | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2020 | |
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Fran Holding AB
Implant Solutions West AB Board members of Implant Solutions West AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Lars Johan Magnusson | Audit | 0 companies |
| Anders Stig Arthur Sandquist | Audit | 0 companies |
| Ludwig Harald Roger Hansson | Chairman | 0 companies |
| Anna Brita Ulrica Hansson | Deputy Board Member | 0 companies |
| Johan William Arneklev | Board of Directors | 0 companies |